Cue Biopharma (CUE) announced that it is commencing an underwritten public offering of shares of its common stock and accompanying warrants to purchase shares of common stock. All of the securities are being offered by Cue Biopharma. Oppenheimer & Co. is acting as sole book-running manager for the offering. Newbridge Securities is acting as co-manager for the offering.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CUE:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue